John Slevin
Professor – Department of Neurology · University of Kentucky College of Medicine
Credentials: · · · ·
History
- 1983–1984
- 1979–1983
University of Virginia Hospital
Research
Journal of neurosurgery · 2005 · First of 6 authors · Corresponding · 378 citations
HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity
Journal of Neurochemistry · 2001 · 226 citations
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
Neurology · 2012 · 224 citations
9 papers
- CS
8 papers
8 papers
8 papers
7 papers
7 papers
6 papers
- JC
6 papers
Grants
- 2024–2029
Phase I Cell Therapy for Maintaining Cholinergic Circuits in the Spectrum of Alzheimer’s Disease
National Institute on Aging · R01
PI · $2M · University of Kentucky
- 2019–2023
Optogenetics: A Tool to Probe Mechanism and an Agent to Block TBI-Induced Epileptogenesis.
Department of Veterans Affairs · I01
Contact PI · Va Medical Center - Lexington, Ky
- 2010–2014
TBI Epileptogenesis: Pathologic Hippocampal L-Glut Synaptic Plasticity
Department of Veterans Affairs · I01
Contact PI · Va Medical Center - Lexington, Ky
- 2006–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1.7K · University of Kentucky
Clinical trials
- 2018–2029
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
Principal investigator · Recruiting
Zabeen Mahuwala, MD
- 2009
Trichloroethylene (TCE) Exposure in an Industrial Population
Principal investigator · Completed
University of Kentucky
- 2025–2028
Site PI · Recruiting · Phase 2
Neuron23 Inc.